Skip to main content
. 2018 Jul 24;16:114. doi: 10.1186/s12916-018-1105-8

Table 2.

Weighted prevalence of the target comorbidities separated by dementia status for those aged 75 and above living in the community for CFAS I and CFAS II. See methods for description of weights

Dementia No dementia
Health condition n Weighted % 95% CI n Weighted % 95% CI
CFAS I 10-year follow-up (n = 1619)
 Stroke 17 22.6 14.0–34.4 143 9.7 8.3–11.4
 Diabetes 13 15.6 6.6–34.8 139 8.6 7.3–10.1
 Visual impairment 19 21.7 13.5–32.9 159 11.4 9.7–13.2
 Target comorbidities 41 47.6 36.5–58.8 375 25.4 23.2–27.7
CFAS II baseline (n = 3805)
 Stroke 47 17.9 13.3–23.8 330 9.7 8.8–10.8
 Diabetes 42 16.2 11.8–21.9 498 14.3 13.2–15.6
 Visual impairment 39 16.7 12.1–22.6 563 17.3 16.0–18.7
 Target comorbidities 100 35.7 29.7–42.1 1194 35.1 33.5–36.8